---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042172"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2024-10-23T23:59:59+00:00"
generated_at: "2026-05-30T11:00:47.307212+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lixte Biotechnology gets Nasdaq extension to Feb 18, 2025 to meet equity requirement

## Summary
- Nasdaq notified non-compliance with $2.5M minimum stockholders' equity requirement.
- Company submitted compliance plan; Nasdaq granted extension until February 18, 2025.
- Filed S-1 registration statement to raise up to $4.0M in equity capital.
- Failure to evidence compliance by March 31, 2025 may lead to delisting.
- Common stock and warrants continue trading on Nasdaq under LIXT and LIXTW.

## SEC filing metadata
- accession: 0001493152-24-042172
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2024-10-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315224042172/0001493152-24-042172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315224042172/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042172
- JSON: https://secwatch.observer/filing/0001493152-24-042172.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042172.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.